| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |